교합 디바이스 시장 규모, 점유율, 성장 분석 : 제품별, 용도별, 최종사용자별, 지역별 - 산업 예측(2025-2032년)
Occlusion Devices Market Size, Share, Growth Analysis, By Product (Occlusion Removal Devices, Embolization Devices), By Application (Neurology, Cardiology), By End User, By Region - Industry Forecast 2025-2032
상품코드:1633663
리서치사:SkyQuest
발행일:2025년 01월
페이지 정보:영문 232 Pages
라이선스 & 가격 (부가세 별도)
한글목차
세계의 교합 디바이스 시장 규모는 2023년에 29억 4,000만 달러에 달하며, 예측 기간(2025-2032년)의 CAGR은 5.1%로, 2024년 30억 9,000만 달러에서 2032년에는 46억 달러로 성장할 전망입니다.
세계 교합 디바이스 시장은 심혈관 질환, 신경혈관 질환, 말초 혈관 질환의 유병률 증가에 힘입어 견고한 성장 궤도에 있습니다. 폐색제거 장비, 색전술 장비, 지지 장비 등의 주요 제품은 효과적인 치료 프로토콜에 필수적인 제품입니다. 고령화와 최소 침습 수술 기술의 발전은 시장 확대를 더욱 촉진하고 있습니다. 또한 혈관내 치료로의 전환과 외래수술센터(ASC)와 같은 외래 환자 선호도가 높아지면서 수요가 증가하고 있습니다. 북미는 심혈관 질환의 높은 유병률과 주요 제조업체의 존재로 인해 시장을 주도하고 있습니다. 반면, 유럽과 아시아태평양은 의료 인프라가 개선되고 환자들의 인식이 높아지면서 큰 성장세를 보이고 있습니다. 이러한 추세는 가까운 미래에도 지속될 것으로 예상됩니다.
목차
서론
조사의 목적
조사 범위
정의
조사 방법
정보 조달
2차 데이터와 1차 데이터 방법
시장 규모 예측
시장의 전제조건과 제한
개요
세계 시장 전망
공급과 수요의 동향 분석
부문별 기회 분석
시장 역학과 전망
시장 개요
시장 규모
시장 역학
촉진요인과 기회
억제요인과 과제
Porter의 산업 분석
주요 시장 인사이트
주요 성공 요인
경쟁의 정도
주요 투자 기회
시장 에코시스템
시장의 매력 지수(2024년)
PESTEL 분석
거시경제 지표
밸류체인 분석
가격 분석
규제 상황
사례 연구
기술의 진보
교합 디바이스 시장 규모 : 제품별과 CAGR(2025-2032년)
시장 개요
폐쇄 제거 기기
풍선 교합 디바이스
스텐트 회수기
코일 리트리버
석션·흡인 디바이스
색전 디바이스
색전코일
액체색전제
Tubal Occlusion Devices
서포트 디바이스
마이크로카테터
가이드와이어
교합 디바이스 시장 규모 : 용도별과 CAGR(2025-2032년)
시장 개요
신경학
심장병학
말초혈관 질환
비뇨기과
종양학
부인과
교합 디바이스 시장 규모 : 최종사용자별과 CAGR(2025-2032년)
시장 개요
병원
진단 센터
외과 센터
외래 진료 센터
조사실 및 학술기관
교합 디바이스 시장 규모와 CAGR(2025-2032년)
북미
미국
캐나다
유럽
독일
스페인
프랑스
영국
이탈리아
기타 유럽 지역
아시아태평양
중국
인도
일본
한국
기타 아시아태평양
라틴아메리카
브라질
기타 라틴아메리카 지역
중동 및 아프리카
GCC 국가
남아프리카공화국
기타 중동 및 아프리카
경쟁 정보
상위 5사의 비교
주요 기업의 시장 포지셔닝(2024년)
주요 시장 기업이 채택한 전략
시장의 최근 동향
기업의 시장 점유율 분석(2024년)
주요 기업의 기업 개요
회사 개요
제품 포트폴리오 분석
부문별 점유율 분석
매출의 전년대비 비교(2022-2024년)
주요 기업 개요
Boston Scientific Corporation(United States)
Medtronic PLC(Ireland)
Terumo Corporation(Japan)
Stryker Corporation(United States)
Penumbra, Inc.(United States)
Abbott Laboratories(United States)
Edwards Lifesciences Corporation(United States)
Johnson & Johnson(United States)
Merit Medical Systems, Inc.(United States)
Lepu Medical Technology Co., Ltd.(China)
Asahi Intecc Co., Ltd.(Japan)
AngioDynamics, Inc.(United States)
Cardinal Health, Inc.(United States)
Avinger, Inc.(United States)
B. Braun Melsungen AG(Germany)
C.R. Bard, Inc.(United States)
Cook Medical Incorporated(United States)
Acrostak International Distribution Sarl(Switzerland)
결론과 권장사항
KSA
영문 목차
영문목차
Global Occlusion Devices Market size was valued at USD 2.94 billion in 2023 and is poised to grow from USD 3.09 billion in 2024 to USD 4.6 billion by 2032, growing at a CAGR of 5.1% during the forecast period (2025-2032).
The global occlusion devices market is on a robust growth trajectory, driven by the rising incidence of cardiovascular diseases, neurovascular disorders, and peripheral vascular conditions. Key products including occlusion removal devices, embolization devices, and support devices are integral to effective treatment protocols. The aging population and advancements in minimally invasive surgical techniques are further propelling market expansion. Moreover, the shift towards endovascular procedures and an increasing preference for outpatient settings, like ambulatory surgical centers, are boosting demand. North America leads the market, thanks to a high prevalence of cardiovascular issues and the presence of major manufacturers. Meanwhile, Europe and Asia-Pacific are experiencing significant growth due to enhanced healthcare infrastructure and rising patient awareness. This trend is expected to persist in the near future.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Occlusion Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Occlusion Devices Market Segmental Analysis
Global Occlusion Devices Market is segmented by Product, Application, End User and region. Based on Product, the market is segmented into Occlusion Removal Devices, Embolization Devices and Support Devices. Based on Application, the market is segmented into Neurology, Cardiology, Peripheral Vascular Diseases, Urology,oncologyand Gynecology. Based on End User, the market is segmented into Hospitals, Diagnostic Centers,, Surgical Centers, Ambulatory Care Centers and Research Laboratories & Academic Institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Occlusion Devices Market
The global occlusion devices market is primarily driven by the rising prevalence of cardiovascular and neurovascular diseases, as well as peripheral vascular conditions. The growing incidence of these health issues necessitates effective therapeutic solutions like occlusion devices to restore blood flow and mitigate complications. This demand is further amplified by an aging population and increasing unhealthy lifestyle choices. Additionally, advancements in minimally invasive techniques have transformed occlusion treatment, offering patients non-surgical options that reduce trauma, expedite recovery, and enhance outcomes. The introduction of innovative devices, including occlusion removal and embolization devices, with improved safety and efficacy, is fostering significant market growth.
Restraints in the Global Occlusion Devices Market
The global occlusion devices market faces several significant restraints, primarily due to rigorous regulatory approval processes designed to ensure patient safety and product effectiveness. Securing necessary approvals, such as those from the FDA or obtaining CE marking, is often a lengthy and expensive endeavor. This regulatory landscape presents considerable hurdles, especially for small and medium-sized enterprises looking to enter or enhance their market footprint. Additionally, the high costs associated with manufacturing occlusion devices-encompassing occlusion removal, embolization, and support devices-are another limiting factor. The substantial expenses tied to research, development, and the use of specialized materials drive up prices, restricting market access and adoption, particularly in regions with constrained healthcare budgets and emerging economies where affordability is a critical concern.
Market Trends of the Global Occlusion Devices Market
The Global Occlusion Devices market is witnessing a significant shift towards bioresorbable occlusion devices, driven by their ability to dissolve and be absorbed by the body, thereby eliminating the need for device removal procedures. This burgeoning demand is largely fueled by the advantages these devices offer, including minimized long-term complications and enhanced patient comfort. Manufacturers are increasingly channeling investments into research and development to refine bioresorbable materials, focusing on boosting safety and efficacy. This trend reflects a broader movement toward patient-centric healthcare solutions, highlighting a growing preference for personalized treatment options within the realm of occlusion device interventions.
Table of Contents
Introduction
Objectives of the Study
Scope of the Report
Definitions
Research Methodology
Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations
Executive Summary
Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis
Market Dynamics & Outlook
Market Overview
Market Size
Market Dynamics
Drivers & Opportunities
Restraints & Challenges
Porters Analysis
Competitive rivalry
Threat of substitute
Bargaining power of buyers
Threat of new entrants
Bargaining power of suppliers
Key Market Insights
Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Landscape
Case Studies
Technological Advancement
Global Occlusion Devices Market Size by Product & CAGR (2025-2032)
Market Overview
Occlusion Removal Devices
Balloon Occlusion Devices
Stent Retrievers
Coil Retrievers
Suction & Aspiration Devices
Embolization Devices
Embolic Coils
Liquid Embolic Agents
Tubal Occlusion Devices
Support Devices
Microcatheters
Guidewires
Global Occlusion Devices Market Size by Application & CAGR (2025-2032)
Market Overview
Neurology
Cardiology
Peripheral Vascular Diseases
Urology
Oncology
Gynecology
Global Occlusion Devices Market Size by End User & CAGR (2025-2032)
Market Overview
Hospitals
Diagnostic Centers,
Surgical Centers
Ambulatory Care Centers
Research Laboratories & Academic Institutes
Global Occlusion Devices Market Size & CAGR (2025-2032)
North America (Product, Application, End User)
US
Canada
Europe (Product, Application, End User)
Germany
Spain
France
UK
Italy
Rest of Europe
Asia Pacific (Product, Application, End User)
China
India
Japan
South Korea
Rest of Asia-Pacific
Latin America (Product, Application, End User)
Brazil
Rest of Latin America
Middle East & Africa (Product, Application, End User)
GCC Countries
South Africa
Rest of Middle East & Africa
Competitive Intelligence
Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
Company Details
Product Portfolio Analysis
Company's Segmental Share Analysis
Revenue Y-O-Y Comparison (2022-2024)
Key Company Profiles
Boston Scientific Corporation (United States)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Medtronic PLC (Ireland)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Terumo Corporation (Japan)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Stryker Corporation (United States)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Penumbra, Inc. (United States)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Abbott Laboratories (United States)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Edwards Lifesciences Corporation (United States)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Johnson & Johnson (United States)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Merit Medical Systems, Inc. (United States)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Lepu Medical Technology Co., Ltd. (China)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Asahi Intecc Co., Ltd. (Japan)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
AngioDynamics, Inc. (United States)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Cardinal Health, Inc. (United States)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Avinger, Inc. (United States)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
B. Braun Melsungen AG (Germany)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
C.R. Bard, Inc. (United States)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Cook Medical Incorporated (United States)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Acrostak International Distribution Sarl (Switzerland)